Dr Yusuf K Hamied: India's generics king

Generics |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2012

Dr Yusuf K Hamied, CMD of India's largest pharma company, Cipla, has earned many unflattering epithets for building a co...Read more

India to realign regulatory with pharma industry

Generics |  Opinion | By Nandita Singh | 2 Comment | 06 Jun, 2012

India's top drug regulatory body, the Central Drug Standard Control Organization (CDSO) is literally facing the heat, th...Read more

Sun Pharma generic testosterone injection gets FDA nod

Generics |  Regulatory | By BioSpectrum Bureau  | 4 Comment | 06 Jun, 2013

Mumbai: Sun Pharmaceutical Industries received final approval from the US FDA for its abbreviated new drug application (...Read more

GlobalData: New Zealand focuses on generics

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 27 Feb, 2013

Singapore: A new study by GlobalData has revealed that New Zealand's Pharmaceutical Management Agency's (PHARMAC) is emp...Read more

Lilly expands partnership with Novast

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2012

Singapore: In support of its commitment to maximize growth opportunities in China, Eli Lilly has decided to increase its...Read more

Gulf nations woo Indian generic firms

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Apr, 2013

Singapore: A new report by investment bank Alpen Capital titled, 'The GCC pharmaceutical Outlook', a number of Gulf Coop...Read more

Japan's Meiji Seika Pharma buys Medreich

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 27 Jun, 2014

Singapore: Japan's Meiji Seika Pharma is set to acquire Bangalore-based generic drug maker Medreich for $290 million. Th...Read more

China cracks the whip on big pharma

Generics |  Opinion | By BioSpectrum Bureau  | 0 Comment | 02 Jun, 2014

Two separate but equally important developments took place in China this month. One, intensification of investigations i...Read more

Mylan to produce generic of Gilead's HIV drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 03 Aug, 2012

Singapore: Mylan signed a new agreement between its subsidiary Mylan Laboratories and Gilead Sciences. According top thi...Read more

Actavis to sell generic AstraZeneca's Crestor

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 26 Mar, 2013

Singapore: US-based Actavis reached a settlement agreement with AstraZeneca resolving outstanding patent litigation rela...Read more

Pfizer, GSK sign productivity pact with Singapore's A*Star

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

Singapore: Pharma industry leaders Pfizer and GlaxoSmithKline have joined hands with global engineering giants Siemens t...Read more

HIV generics to take over antivirals market

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2012

Singapore: Generics are predicted to take over the antiviral drugs market, especially in the case of HIV medication, as ...Read more

Fujifilm, Dr Reddy's terminate generics JV

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

Hyderabad: Fujifilm and Dr Reddy's Laboratories have decided to terminate the memorandum of understanding (MoU) to enter...Read more

Dr Reddy's launches generic fracture drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 07 Mar, 2013

Hyderabad: Dr Reddy's Laboratories (DRL) launched Zoledronic Acid Injection (4 mg/5 mL), a bioequivalent generic versio...Read more

GSK executives confessed to bribery charges: China

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 12 Jul, 2013

Singapore: Two weeks after intense investigations into GlaxoSmithKline's (GSK) operations across China, the country's se...Read more

Ranbaxy to market Desvenlafaxine in the US

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 06 Mar, 2013

Bangalore: Ranbaxy Pharmaceuticals, a wholly owned subsidiary of Ranbaxy Laboratories, has entered into an in-licensing...Read more

India to review its pharma FDI policies

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2013

New Delhi: The Indian government will be reviewing the foreign direct investment (FDI) policies for the pharmaceutical i...Read more

DCGI nod for Zydus Cadila diabetic dyslipidemeia drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jun, 2013

Singapore: Days after the Drug Controller General of India (DCGI) approved Cadila Healthcare's new chemical entity, Lipa...Read more